Abstract

Conjugation of small molecules to proteins through N-hydroxysuccinimide (NHS) esters results in a random distribution of small molecules on lysine residues and the protein N-terminus. While mass spectrometry methods have improved characterization of these protein conjugates, it remains a challenge to quantify the occupancy at individual sites of conjugation. Here, we present a method using Tandem Mass Tags (TMT) that enabled the accurate and sensitive quantification of occupancy at individual conjugation sites in the NIST monoclonal antibody. At conjugation levels relevant to antibody drug conjugates in the clinic, site occupancy data was obtained for 37 individual sites, with average site occupancy data across 2 adjacent lysines obtained for an additional 12 sites. Thus, altogether, a measure of site occupancy was obtained for 98% of the available primary amines. We further showed that removal of the Fc-glycan on the NIST mAb increased conjugation at two specific sites in the heavy chain, demonstrating the utility of this method to identify changes in the susceptibility of individual sites to conjugation. This improved site occupancy data allowed calibration of a bi-parametric linear model for predicting the susceptibility of individual lysines to conjugation from 3D-structure based on their solvent exposures and ionization constants. Trained against the experimental data for lysines from the Fab fragment, the model provided accurate predictions of occupancies at lysine sites from the Fc region and the protein N-terminus (R2 = 0.76). This predictive model will enable improved engineering of antibodies for optimal labeling with fluorophores, toxins, or crosslinkers.

Highlights

  • Conjugation of small molecules to antibodies and other proteins is widely used to produce both therapeutics and assay reagents[1]

  • To determine the site occupancy of individual lysines after conjugation to an NHS-ester based molecule, we developed a method that relies on the relative quantitative accuracy enabled by the commercially available Tandem Mass Tags (TMT) reagents, which contain an NHS ester for conjugation

  • TMT127 has the same structure and molecular weight as the TMT126 used in the original conjugate and differs only in the location of a 13C isotope

Read more

Summary

Introduction

Conjugation of small molecules to antibodies and other proteins is widely used to produce both therapeutics and assay reagents[1]. Several mass spectrometry (MS) approaches have been used to provide some information on site occupancy at individual lysines in ADCs by comparing the ion signal for conjugated peptides relative to unconjugated ones[7,8] This can be done with or without correction for differences in ionization efficiency between these two species. These studies provided site occupancy data for a limited number of lysine sites, and the accuracy of their measurements was difficult to assess due to the inherent difficulties in comparing two different peptide species These ‘apples-to-oranges’ comparisons are complicated by the fact that conjugation can affect the ionization and chromatographic properties of a peptide, and the local susceptibility to protease digestion, even when non-specific or non-lysine dependent proteases are used

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.